节律制药 RYTM
$112.28 +$7.26 (+6.91%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $112.80 +0.46%
开盘$107.10
昨收$105.02
当日区间$104.31 – $113.29
成交量4.94M
市值$7.78B
市盈率（TTM）–
股息率–
RYTM 相关新闻
匹配 Rhythm Pharmaceuticals 或代码 RYTM 的头条新闻，按最新排序。
- Wolfe Research Initiates Rhythm Pharmaceuticals(RYTM.US) With Buy Rating
- J.P. Morgan Remains a Buy on Rhythm Pharmaceuticals (RYTM)
- J.P. Morgan Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating
- RBC Capital Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $155
- Form 144 | Rhythm Pharmaceuticals(RYTM.US) Director Proposes to Sell 5.24 Million in Common Stocks
- A Quick Look at Today's Ratings for Rhythm Pharmaceuticals(RYTM.US), With a Forecast Between $130 to $160
- Morgan Stanley Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Raises Target Price to $150 正面
- CCORF Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Raises Target Price to $154 正面
- Deutsche Bank Initiates Rhythm Pharmaceuticals(RYTM.US) With Hold Rating, Announces Target Price $120
- Morgan Stanley Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $150
- Guggenheim Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $143
- J.P. Morgan Initiates Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Announces Target Price $146
- CCORF Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $151
- RBC Capital Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Raises Target Price to $141 正面
- Wells Fargo Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $155
暂无评论——快来第一个聊聊 RYTM。
登录后参与讨论。